Consolidation Kick-Off?
This article was originally published in Start Up
Executive Summary
Along with plenty of other investors, the Rothschild family is getting out of biotech, as Rothschild Asset Management merges its Rothschild Bioscience unit with Merlin Ventures. Merlin will now have one of the largest funds in the world dedicated to life sciences.